Minimally invasive approaches advance in pediatrics
August 15th 2005Across a spectrum of indications, minimally invasive procedures are having a major impact on the practice of pediatric urology, said Howard Snyder, MD, professor of surgery in urology, University of Pennsylvania School of Medicine and Children's Hospital of Philadelphia. This observation was evident in a number of papers presented at the AUA annual meeting.
Researchers home in on interstitial cystitis genes
August 15th 2005San Antonio--With new technology that performs large-scale genotyping, researchers are homing in on the genes responsible for interstitial cystitis. It won't be long before they know what those genes are, and a specific drug target or even gene therapy for IC could soon follow.
Age is not a predictor of prostatectomy outcomes
August 15th 2005San Antonio--Youth, usually seen as an asset in clinical situations, confers no advantage in clinical outcomes following radical prostatectomy. In fact, a study from the Mayo Clinic, Rochester, MN, found that high-risk patients younger than age 55 years were more likely to suffer systemic disease progression than older, high-risk patients and that age at treatment offers little to no prognostic value when all other clinical factors are being considered.
BPH data reveal key findings on epidemiology, treatment
August 15th 2005The 2005 AUA annual meeting in San Antonio proved to be fertile ground for research on both epidemiologic trends and clinical aspects of benign prostatic hyperplasia and lower urinary tract symptoms—medical therapy, minimally invasive treatments, and phytotherapy. Data from several key studies appeared to clarify the role of various treatment modalities in selected patient populations. Not all the news was positive, however, as one study showed no significant effect with saw palmetto, a commonly used herbal therapy.
Program improves bladdercontrol in as few as 6 weeks
August 15th 2005The evadri Bladder Control System from Hollister, Inc. is an office-based pelvic floor muscle retraining program that includes six to eight sessions of lifestyle adjustment, monitored Kegel exercises, and biofeedback combined with a home-based exercise program for effective bladder control in as few as 6 weeks.
Single-dose carboplatin is effective against testicular cancer
August 4th 2005Scientists in the United Kingdom report that a single dose of carboplatin (Paraplatin) after surgery for early testicular cancer is as safe and effective as 2 to 3 weeks of radiotherapy after surgery, with less toxicity, and with durable results.
PSA isoform may provide more specific test for BPH
August 4th 2005An investigational laboratory test known as BPH-A may help identify BPH, researchers reported at a joint meeting of the International Federation of Clinical Chemistry and Laboratory Medicine and American Association for Clinical Chemistry in Orlando, FL.
Three factors identify prostate Ca patients who need further treatment
August 4th 2005Three risk factors--PSA doubling time, Gleason score, and time from surgery to biochemical recurrence--can be used to determine whether to treat patients aggressively or carefully following radical prostatectomy for prostate cancer, according to a study published last week in JAMA (2005; 294:433-9).
Text explores lower urinarytract diagnostic methods
August 1st 2005Imaging and Urodynamics of the Lower Urinary Tract is a new textbook from publishers Taylor & Francis. The book is a comprehensive reference on lower urinary tract imaging and nonendoscopic assessment, divided into separate sections on the bladder and the urethra.
Routine bladder cancer slide reviews need not be routine
August 1st 2005San Antonio--Although it may be routine at any number of tertiary care institutions and centers of excellence, the practice of automatically reviewing pathology slides that accompany referred bladder cancer patients nets little gain for either physicians or patients. In an overwhelming majority of instances, the practice does little more than add unnecessary dollars to the cost of treatment, according to a study presented at the 2005 AUA annual meeting here.
Optimal therapy for locally advanced bladder cancer ups survival
August 1st 2005Orlando, FL--Radical cystectomy with pelvic lymph node dissection is the mainstay surgical treatment of locally advanced bladder cancer. Despite aggressive surgery, half of patients experience recurrence and die of the disease following cystectomy alone. However, there is evidence that patients receiving optimizing therapy (ie, neoadjuvant chemotherapy before cystectomy, radical cystectomy, and adequate lymph node dissection) have prolonged survival, compared with those treated with cystectomy only.
Intravesical chemo shows benefit in Ta bladder cancer
August 1st 2005Orlando, FL--Gemcitabine (Gemzar) administered as an intravesical instillation appears to be well tolerated and to demonstrate modest efficacy in patients with stage Ta, grade I/II urinary bladder cancer, with about one-third of patients achieving a response. However, a twice-weekly dose given for 3 weeks is comparable in efficacy to a once-weekly dose given for 6 weeks, a new study suggests, and a single dose given once is not effective in this patient population.
Ureteroscopy preferred to ESWL for proximal stones
August 1st 2005San Antonio--Ureteroscopy is associated with significantly better outcomes than extracorporeal shock wave lithotripsy (ESWL) for the treatment of proximal ureteral stones, according to the results of a prospective randomized study undertaken by urologists at the University of Innsbruck, Austria. The researchers now recommend the ureteroscopic approach as first-line treatment for proximal stones, they said at the 2005 AUA annual meeting here.
Agent significantly extends RCC patients' lives
August 1st 2005Orlando, FL--An investigational agent that inhibits both Raf kinase and vascular endothelial growth factor receptor significantly prolongs progression-free survival in pa-tients with advanced renal cell carcinoma, according to results of a phase III clinical trial presented at the American Society for Clinical Oncology annual meeting here.
Physician-owned hospitals face restrictions, referral cuts
August 1st 2005Washington--The federal government is preparing restrictions on the physician-owned specialty hospital industry, an emerging field it says could be a financial boon to physician investors and unfair competition to traditional hospitals and ambulatory surgery centers.
The group shared appointment: How it works and how it helps
August 1st 2005According to a 2004 AUA survey, urologists are working harder and longer than ever. An aging population combined with the training of fewer urologists (many of whom wish to limit work hours) has created an unprecedented workload.
JIB reversal improves, but does not remove, stone risk
August 1st 2005San Antonio--Jejuno-ileal bypass (JIB) reversal improves urinary stone risk factors, although preventing stone recurrence may require alkalinization therapy to normalize urinary citrate excretion, according to a study conducted by researchers at The Cleveland Clinic.
High-calcium diet may raise risk of stone formation
August 1st 2005San Antonio--People who receive a high-calcium diet in the setting of liberal oxalate intake may be at increased risk for calcium oxalate stone formation, according to the results of a small metabolic study reported at the 2005 AUA annual meeting here.